Paloma Partners Management CO Medicinova Inc Transaction History

Paloma Partners Management CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$2.9 - $6.97 $35,090 - $84,337	-12,100 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$6.48 - $8.76 $78,408 - $105,996	12,100 New	12,100 $82,000
Q1 2018 May 15, 2018	SELL	$6.6 - $13.91 $202,309 - $426,383	-30,653 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$5.89 - $7.21 $180,546 - $221,008	30,653	30,653 $198,000

4.83M

9.4K

Ticker MNOV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,046,200
Market Cap $89.8M
Description
MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and ...

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

Stay updated on Paloma Partners Management CO with notifications on news.